Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases
Simone Lista(Universidad Europea Miguel de Cervantes), Robert Nisticò(Magna Graecia University)
Cited by 40
Related Papers
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis
|Philosophical Transactions of the Royal Society B Biological Sciences|2013|53